Lessons from“real life experience”of rifaximin use in the management of recurrent hepatic encephalop

• 作 者: Fiona Chautant Maeva Guillaume
• 机 构: ServicePharmacie,DepartmentofHepato-Gastroenterology,DepartmentofHepato-Gastroenterology,Departmento
• 出 处: 世界肝病学杂志:英文版(电子版)
• 发表日期: 2020年1期
• 关键词: RIFAXIMIN Hepatic ENCEPHALOPATHY CIRRHOSIS Liver disease HOSPITALIZATION

BACKGROUND Hepatic encephalopathy(HE)is a major complication of cirrhosis with independent prognostic significance.The current management of HE is mainly based on lactulose.Rifaximin has been shown to decrease the risk of HE recurrence in patients with ep